SCM
HQL

Saba Capital Management’s abrdn Life Sciences Investors HQL Stock Holding History

Saba Capital Management’s Portfolio HQL Stock Details HQL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.56M Sell
78,095
-869,251
-92% -$15.4M 0.04% 194
2026
Q1 		$15.4M Sell
947,346
-1,169,828
-55% -$19.6M 0.43% 56
2025
Q4 		$35.5M Sell
2,117,174
-469,478
-18% -$7.89M 1.06% 18
2025
Q3 		$40.1M Sell
2,586,652
-430,887
-14% -$5.9M 1.1% 19
2025
Q2 		$38.7M Sell
3,017,539
-170,866
-5% -$2.11M 0.91% 24
2025
Q1 		$40.5M Sell
3,188,405
-241,618
-7% -$3.27M 1.09% 19
2024
Q4 		$45M Buy
3,430,023
+32
+0% +$462 1.05% 21
2024
Q3 		$51.7M Hold
3,429,991
– – 1.08% 25
2024
Q2 		$48.6M Buy
3,429,991
+967,844
+39% +$13.1M 0.81% 25
2024
Q1 		$33.6M Buy
2,462,147
+1,040,847
+73% +$14.4M 0.57% 30
2023
Q4 		$19.1M Buy
1,421,300
+1,149,693
+423% +$14.1M 0.38% 71
2023
Q3 		$3.39M Buy
271,607
+134,644
+98% +$1.77M 0.08% 174
2023
Q2 		$1.85M Buy
+136,963
New +$1.89M 0.05% 232

Other funds holding HQL

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
PCM
Penserra Capital Management Orinda, California $13B AUM 71.84% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $65.2B AUM 39.42% 1-Year Est. Return
NIM
Needham Investment Management New York $3.33B AUM 163.16% 1-Year Est. Return
FHA
Flagship Harbor Advisors Boston, Massachusetts $2.61B AUM 23.21% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.56B AUM 35.09% 1-Year Est. Return
1WA
180 Wealth Advisors Federal Way, Washington $997M AUM 47.84% 1-Year Est. Return

Saba Capital Management's HQL Position: Q2 2026 in Review

Saba Capital Management reduced its abrdn Life Sciences Investors (HQL) stake by 92% in Q2 2026, selling an estimated $15.4M and leaving 78,095 shares worth $1.56M. The position accounts for 0.04% of the portfolio, ranked #194.

Saba Capital Management first reported a position in HQL in Q2 2023 and has held it in 13 quarters since. The position peaked at $51.7M in Q3 2024. 83 funds tracked by Wall St. Rank hold HQL as of Q2 2026.

  • Saba Capital Management held 78,095 shares of abrdn Life Sciences Investors worth $1.56M as of Q2 2026.
  • Saba Capital Management sold 869,251 abrdn Life Sciences Investors shares in Q2 2026, an estimated $15.4M.
  • abrdn Life Sciences Investors made up 0.04% of Saba Capital Management's portfolio in Q2 2026, its #194 holding.
  • Saba Capital Management first reported a position in abrdn Life Sciences Investors in Q2 2023 and has held it in 13 quarters since.
  • Saba Capital Management's abrdn Life Sciences Investors position peaked at $51.7M in Q3 2024.
  • 83 funds tracked by Wall St. Rank held abrdn Life Sciences Investors as of Q2 2026.

Based on Saba Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.